SCHEMBL18399007

SCHEMBL18399007

O=C(O)c1ccc2cnn(C3CCCCO3)c2c1

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
RXRA P19793 1/20 0.56
RXRB P28702 1/20 0.56
RXRG P48443 1/20 0.56
HCAR3 P49019 6/20 0.42
ALDH1A1 P00352 1/20 0.42
LMNA P02545 1/20 0.42
POLB P06746 1/20 0.42
KHK P50053 2/20 0.42
CYP4F2 P78329 3/20 0.41
CYP4A11 Q02928 3/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
ATR Q13535 1/20 0.40
HSD17B10 Q99714 1/20 0.40
GAA P10253 1/20 0.40
HTR1A P08908 1/20 0.38
HTR1B P28222 1/20 0.38
HTR1F P30939 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30151185 1.00 RXRA (0.56) RXRARXRBRXRGHCAR3ALDH1A1
SCHEMBL19328918 0.90 RXRA (0.52) RXRARXRBRXRGALDH1A1LMNA
SCHEMBL20271725 0.90 RXRA (0.65) RXRARXRBRXRGHCAR3ALDH1A1
SCHEMBL29518728 0.90 RXRA (0.65) RXRARXRBRXRGHCAR3ALDH1A1
SCHEMBL24900263 0.88 RXRA (0.50) RXRARXRBRXRGALDH1A1LMNA
SCHEMBL31191358 0.87 RXRA (0.49) RXRARXRBRXRGALDH1A1LMNA
SCHEMBL30050315 0.84 RXRA (0.53) RXRARXRBRXRGALDH1A1LMNA
SCHEMBL18399121 0.84 RXRA (0.53) RXRARXRBRXRGALDH1A1LMNA
SCHEMBL7419168 0.84 HCAR3 (0.56) HCAR3ALDH1A1KHKL3MBTL1HSD17B10
SCHEMBL31191317 0.83 RXRA (0.46) RXRARXRBRXRGALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115715292-A 1H-pyrazolo [4,3-g ] isoquinoline and 1H-pyrazolo [4,3-g ] quinoline derivatives as alpha-1-antitrypsin modulators for the treatment of alpha-1-antitrypsin deficiency (AATD) 弗特克斯药品有限公司 2023-02-24 CN disclosed
EP-3325449-A1 COMPOUNDS GlaxoSmithKline Intellectual Property Development Limited (GB) 2018-05-30 EP disclosed
WO-2017012576-A1 COMPOUNDS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2017-01-26 WO disclosed